Further research uncovered a broad
spectrum of cell surface stem cell
markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in human solid
tumors, including brain, breast, prostate, pancreas, liver, ovary, skin, colon cancers, and melanoma (3 - 6)(Figure 1 based on 7).